Posts filed under ‘Clinical trials’

PLos debates professional writers

Call for transparency when using professional medical writers


Continue Reading February 13, 2009 at 3:53 pm Leave a comment

New legislation and guidelines for medical communications

A great overview on the global implications of FDAAA Legislation, as written by Liz Wager, is now accessible at the website. The follow-on to Liz’s first Good Publication Practice Guidelines, the so-called GPP2 are in development, as discussed in an article in Pharmaceutical Marketing Europe, January/February 2009 issue. I can’t see it yet on the website ( but it may appear soon.

Further to Jane MacDougall’s comment, you can find Liz’s article: Medical Writers and Peer-Reviewed Journals: Understanding the Rules and Responsibilities here.

January 21, 2009 at 7:37 pm 1 comment



Previously on Medical Communicating…